PanTera Raises $104.1 Million to Boost Global Production
Deal News | Nov 28, 2024 | Oaklins Cavendish
PanTera, a Belgian radioisotope producer, successfully closed a Series A fundraising round, raising $104.1 million (€93 million). The oversubscribed round was led by an undisclosed consortium and advised by Oaklins Cavendish. The funds will be used to expand PanTera's global production capabilities, emphasizing their commitment to addressing the growing demand for radioisotopes worldwide. With this new capital, PanTera aims to enhance its production infrastructure and distribute its products more widely, signifying a significant step in its global expansion strategy.
Sectors
- Healthcare
- Nuclear Technology
- Financial Advisory
Geography
- Belgium – PanTera is based in Belgium, which is central to the company's operations and fundraising activities.
Industry
- Healthcare – The article relates to PanTera's production of radioisotopes, which are crucial for medical imaging and treatments.
- Nuclear Technology – PanTera's work with radioisotopes involves the use of nuclear technology, which is integral to their production and application.
- Financial Advisory – Oaklins Cavendish's role as an advisor in the fundraising round highlights the involvement of financial services in capital raising activities.
Financials
- US$104.1 million – Total amount raised by PanTera in its Series A fundraising round.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| PanTera | Target Company | Company | A Belgian producer of radioisotopes looking to expand its global production capabilities. |
| Oaklins Cavendish | Financial Advisor | Company | An advisory firm that advised on PanTera's Series A fundraising round. |